{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T02:39:00Z","timestamp":1789439940532,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.msard.2023.104693","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T15:44:12Z","timestamp":1680277452000},"page":"104693","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Prevalence of comorbidities in patients with multiple sclerosis using administrative data from 2007 to 2016 in Iran"],"prefix":"10.1016","volume":"74","author":[{"given":"Zahra","family":"Amiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Azmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva","family":"Amiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Akbarisari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ali","family":"Sahraian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshad","family":"Farzadfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6920-8796","authenticated-orcid":false,"given":"Fatemeh","family":"Soleymani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.msard.2023.104693_bib0024","article-title":"Age standardization of rates: a new WHO standard","volume":"9","author":"Ahmad","year":"2001","journal-title":"Geneva: World Health Organization"},{"issue":"2","key":"10.1016\/j.msard.2023.104693_bib0002","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/002580240204200207","article-title":"Pattern of fatal head injuries in Ibadan\u2014a 10 year review","volume":"42","author":"Akang","year":"2002","journal-title":"Med., Sci. Law."},{"issue":"6","key":"10.1016\/j.msard.2023.104693_bib0037","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.jacl.2018.08.001","article-title":"The prevalence, awareness, and treatment of lipid abnormalities in Iranian adults: surveillance of risk factors of noncommunicable diseases in Iran 2016","volume":"12","author":"Aryan","year":"2018","journal-title":"J. Clin. Lipidol."},{"issue":"2","key":"10.1016\/j.msard.2023.104693_bib0030","first-page":"147","article-title":"Gender differences in the utilization of health care services","volume":"49","author":"Bertakis","year":"2000","journal-title":"J. Fam. Pract."},{"key":"10.1016\/j.msard.2023.104693_bib0023","first-page":"99","article-title":"Age-standardisation and denominators","volume":"9","author":"Boniol","year":"2007","journal-title":"Cancer Incidence Five Continents"},{"key":"10.1016\/j.msard.2023.104693_bib0013","series-title":"Polypharmacy in Multiple Sclerosis: More is not Necessarily Better","author":"Bourdette","year":"2022"},{"key":"10.1016\/j.msard.2023.104693_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.829331","article-title":"Late-onset MS: disease course and safety-efficacy of DMTS","volume":"13","author":"Buscarinu","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2023.104693_bib0042","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.msard.2016.10.003","article-title":"A systematic review of anxiety amongst people with Multiple Sclerosis","volume":"10","author":"Butler","year":"2016","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"7","key":"10.1016\/j.msard.2023.104693_bib0051","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1210\/jc.2004-2326","article-title":"Long-term follow-up of 106 multiple sclerosis patients undergoing interferon-\u03b2 1a or 1b therapy: predictive factors of thyroid disease development and duration","volume":"90","author":"Caraccio","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.msard.2023.104693_bib0040","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1176\/appi.ajp.159.11.1862","article-title":"Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample","volume":"159","author":"Chwastiak","year":"2002","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.msard.2023.104693_bib0048","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1191\/1352458503ms921oa","article-title":"Longitudinal evaluation of depression and anxiety in patients with clinically isolated syndrome at high risk of developing early multiple sclerosis","volume":"9","author":"Di Legge","year":"2003","journal-title":"Mult. Scler."},{"issue":"9","key":"10.1016\/j.msard.2023.104693_bib0035","article-title":"Protocol design for large\u2013scale cross\u2013sectional studies of surveillance of risk factors of non\u2013communicable diseases in Iran: STEPs 2016","volume":"20","author":"Djalalinia","year":"2017","journal-title":"Arch. Iran. Med."},{"issue":"5","key":"10.1016\/j.msard.2023.104693_bib0015","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1007\/s00415-012-6790-1","article-title":"Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis","volume":"260","author":"Dobson","year":"2013","journal-title":"J. Neurol."},{"issue":"10","key":"10.1016\/j.msard.2023.104693_bib0006","first-page":"596","article-title":"Late-onset multiple sclerosis in Isfahan, Iran","volume":"15","author":"Etemadifar","year":"2012","journal-title":"Arch. Iran. Med."},{"issue":"5\u20136","key":"10.1016\/j.msard.2023.104693_bib0003","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1159\/000365846","article-title":"Estimated prevalence and incidence of multiple sclerosis in Iran","volume":"72","author":"Etemadifar","year":"2014","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.msard.2023.104693_bib0034","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.msard.2018.08.022","article-title":"Exploring the role of physical activity and exercise for managing vascular comorbidities in people with multiple sclerosis: a scoping review","volume":"26","author":"Ewanchuk","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"2","key":"10.1016\/j.msard.2023.104693_bib0010","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/14740338.2020.1720646","article-title":"Polypharmacy among patients with multiple sclerosis: a qualitative systematic review","volume":"19","author":"Frahm","year":"2020","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.msard.2023.104693_bib0049","doi-asserted-by":"crossref","unstructured":"Frahm, N.; Hecker, M.; Zettl, U.K., Polypharmacy among patients with multiple sclerosis: a qualitative systematic review. Expert Opinion Drug Saf. 2020;19(2):139\u201345.","DOI":"10.1080\/14740338.2020.1720646"},{"issue":"3","key":"10.1016\/j.msard.2023.104693_bib0046","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0013-7006(10)70018-X","article-title":"[Mental Health of elderly people: the prevalence and representations of psychiatric disorders]","volume":"36","author":"Giordana","year":"2010","journal-title":"Encephale"},{"issue":"3","key":"10.1016\/j.msard.2023.104693_bib0001","first-page":"175","article-title":"Multiple sclerosis review","volume":"37","author":"Goldenberg","year":"2012","journal-title":"Pharm. Therapeut."},{"issue":"3","key":"10.1016\/j.msard.2023.104693_bib0029","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/1352458515588973","article-title":"Psychiatric co-morbidity in multiple sclerosis: the risk of depression and anxiety before and after MS diagnosis","volume":"22","author":"Hoang","year":"2016","journal-title":"Multiple Scler. J."},{"issue":"10","key":"10.1016\/j.msard.2023.104693_bib0043","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11910-019-0992-1","article-title":"Depression and suicidality in multiple sclerosis: red flags, management strategies, and ethical considerations","volume":"19","author":"Kalb","year":"2019","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"1","key":"10.1016\/j.msard.2023.104693_bib0041","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12888-020-02579-z","article-title":"Prevalence of anxiety, depression, and stress in patients with multiple sclerosis in Kermanshah-Iran: a cross-sectional study","volume":"20","author":"Karimi","year":"2020","journal-title":"BMC Psychiatry"},{"issue":"8","key":"10.1016\/j.msard.2023.104693_bib0031","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1177\/1352458514557986","article-title":"Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCE","volume":"21","author":"Kieseier","year":"2015","journal-title":"Multiple Scler. J."},{"issue":"2","key":"10.1016\/j.msard.2023.104693_bib0045","article-title":"Pharmacologic treatment of depression in multiple sclerosis","author":"Koch","year":"2011","journal-title":"Cochrane Database System. Rev."},{"issue":"8","key":"10.1016\/j.msard.2023.104693_bib0009","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1136\/jnnp-2017-315907","article-title":"Excess mortality among patients with multiple sclerosis in Denmark has dropped significantly over the past six decades: a population based study","volume":"88","author":"Koch-Henriksen","year":"2017","journal-title":"J. Neurol., Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2023.104693_bib0025","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3389\/fneur.2020.00851","article-title":"Comorbidity in multiple sclerosis","volume":"11","author":"Magyari","year":"2020","journal-title":"Front. Neurol."},{"issue":"9","key":"10.1016\/j.msard.2023.104693_bib0014","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1177\/1352458514521515","article-title":"S\u00f8rensen PS. Gender and autoimmune comorbidity in multiple sclerosis","volume":"20","author":"Magyari","year":"2014","journal-title":"Multiple Scler. J."},{"issue":"2","key":"10.1016\/j.msard.2023.104693_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148573","article-title":"Prevalence of comorbidities, overweight and obesity in an international sample of people with multiple sclerosis and associations with modifiable lifestyle factors","volume":"11","author":"Marck","year":"2016","journal-title":"PLoS ONE"},{"issue":"8","key":"10.1016\/j.msard.2023.104693_bib0016","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1177\/1352458508092263","article-title":"Comorbidity, socioeconomic status and multiple sclerosis","volume":"14","author":"Marrie","year":"2008","journal-title":"Multiple Scler. J."},{"issue":"2","key":"10.1016\/j.msard.2023.104693_bib0011","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1212\/01.wnl.0000333252.78173.5f","article-title":"Comorbidity delays diagnosis and increases disability at diagnosis in MS","volume":"72","author":"Marrie","year":"2009","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.msard.2023.104693_bib0033","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1177\/1352458512437814","article-title":"Rising prevalence of vascular comorbidities in multiple sclerosis: validation of administrative definitions for diabetes, hypertension, and hyperlipidemia","volume":"18","author":"Marrie","year":"2012","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.msard.2023.104693_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2377-13-16","article-title":"Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance","volume":"13","author":"Marrie","year":"2013","journal-title":"BMC Neurol."},{"issue":"2","key":"10.1016\/j.msard.2023.104693_bib0028","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000343188","article-title":"The utility of administrative data for surveillance of comorbidity in multiple sclerosis: a validation study","volume":"40","author":"Marrie","year":"2013","journal-title":"Neuroepidemiology"},{"issue":"3","key":"10.1016\/j.msard.2023.104693_bib0019","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/1352458514564487","article-title":"The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review","volume":"21","author":"Marrie","year":"2015","journal-title":"Multiple Scler. J."},{"issue":"3","key":"10.1016\/j.msard.2023.104693_bib0026","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1177\/1352458514564485","article-title":"A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis","volume":"21","author":"Marrie","year":"2015","journal-title":"Multiple Scler. J."},{"issue":"15","key":"10.1016\/j.msard.2023.104693_bib0018","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1212\/WNL.0000000000002474","article-title":"Recommendations for observational studies of comorbidity in multiple sclerosis","volume":"86","author":"Marrie","year":"2016","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.msard.2023.104693_bib0032","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1212\/CPJ.0000000000000230","article-title":"Differing trends in the incidence of vascular comorbidity in MS and the general population","volume":"6","author":"Marrie","year":"2016","journal-title":"Neurol. Clin. Pract."},{"issue":"2","key":"10.1016\/j.msard.2023.104693_bib0044","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1212\/WNL.0000000000000013","article-title":"Evidence-based guideline: assessment and management of psychiatric disorders in individuals with MS: report of the Guideline Development Subcommittee of the American Academy of Neurology","volume":"82","author":"Minden","year":"2014","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.msard.2023.104693_bib0047","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1212\/01.WNL.0000095964.34294.B4","article-title":"Major depression in multiple sclerosis: a population-based perspective","volume":"61","author":"Patten","year":"2003","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.msard.2023.104693_bib0008","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1046\/j.1532-5415.2001.49038.x","article-title":"Late-onset multiple sclerosis","volume":"49","author":"Polliack","year":"2001","journal-title":"J. Am. Geriatr. Soc."},{"issue":"4","key":"10.1016\/j.msard.2023.104693_bib0007","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.msard.2014.02.004","article-title":"Late onset multiple sclerosis: is it really late onset?","volume":"3","author":"Roohani","year":"2014","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"9","key":"10.1016\/j.msard.2023.104693_bib0036","article-title":"Prevalence of diabetes and prediabetes, and achievements in diabetes control in Iran; the results of the STEPS of 2016","volume":"25","author":"Shahraz","year":"2022","journal-title":"Arch. Iran. Med. (AIM)"},{"issue":"12","key":"10.1016\/j.msard.2023.104693_bib0021","article-title":"Prevalence of dementia and associated factors among older adults in Iran: National Elderly Health Survey (NEHS)","volume":"19","author":"Sharifi","year":"2016","journal-title":"Arch. Iran. Med. (AIM)"},{"issue":"4","key":"10.1016\/j.msard.2023.104693_bib0039","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/jnnp.2004.054635","article-title":"Depression in multiple sclerosis: a review","volume":"76","author":"Siegert","year":"2005","journal-title":"J. Neurol., Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2023.104693_bib0022","first-page":"93","article-title":"Prevalence of asthma, COPD, and chronic bronchitis in Iran: a systematic review and meta-analysis","author":"Varmaghani","year":"2016","journal-title":"Iran. J. Allergy, Asthma Immunol."},{"issue":"3","key":"10.1016\/j.msard.2023.104693_bib0005","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1474-4422(18)30443-5","article-title":"Global, regional, and national burden of multiple sclerosis 1990\u20132016: a systematic analysis for the global burden of disease study 2016","volume":"18","author":"Wallin","year":"2019","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.msard.2023.104693_bib0038","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1177\/1352458513504252","article-title":"Risk factors related to cardiovascular diseases and the metabolic syndrome in multiple sclerosis\u2013a systematic review","volume":"19","author":"Wens","year":"2013","journal-title":"Multiple Scler. J."},{"key":"10.1016\/j.msard.2023.104693_bib0020","series-title":"Guidelines for ATC Classification and DDD Assignment","year":"2021"},{"key":"10.1016\/j.msard.2023.104693_bib0012","doi-asserted-by":"crossref","DOI":"10.1177\/2040622320983121","article-title":"Exploring polypharmacy phenomenon in newly diagnosed relapsing\u2013remitting multiple sclerosis: a cohort ambispective single-centre study","volume":"12","author":"Zangh\u00ec","year":"2021","journal-title":"Ther. Adv. Chronic Dis."},{"issue":"14","key":"10.1016\/j.msard.2023.104693_bib0050","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1212\/WNL.0000000000002543","article-title":"Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis","volume":"86","author":"Zhang","year":"2016","journal-title":"Neurology"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823001979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823001979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:06:53Z","timestamp":1761901613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034823001979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":51,"alternative-id":["S2211034823001979"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2023.104693","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of comorbidities in patients with multiple sclerosis using administrative data from 2007 to 2016 in Iran","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2023.104693","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104693"}}